May 02, 2023 / 06:30PM GMT
Unidentified Analyst
Okay. I'm a senior biotech analyst here at HC Wainwright. And today we're going to have Zomedica present their corporate update. And to present Zomedica, we have Larry Heaton, CEO of Zomedica. Take it away.
Larry Heaton - Zomedica Corp. - CEO
Thank you. Good afternoon. I'm Larry Heaton, I'm the Chief Executive Officer of Zomedica. I am joined here today by Peter Donato, our Chief Financial Officer as well. I thank you for the opportunity to present to you today. And to those of our shareholders who are watching via webcast, we continue to thank you for your support of Zomedica.
We're traded on the New York American exchange under the symbol ZOM. I encourage you to review our Safe Harbor statement at your convenience. At Zomedica, we are competing in the very large, and growing, and recession resistant animal health market, that is been made especially attractive due to the humanization of pets. We offer completely differentiated unique products and technology into the veterinary space. We do this with a very robust and experienced management
Zomedica Corp at H.C. Wainwright BioConnect Investor Conference Transcript
Feb 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers